Effects of deep brain stimulation on olfactory function in Parkinson’s disease
Objective: The aim of this prospective study was to assess the impact of deep brain stimulation (DBS) on olfactory function in Parkinson's disease (PD). Background:…Battery consumption and need for replacement in patients with Parkinson disease treated with interleaved deep brain stimulation
Objective: To evaluate battery life in patients managed with unilateral or bilateral subthalamic nucleus (STN) interleaved deep brain stimulation (DBS) Background: DBS is a common…Long term tremor benefit from cyst formation as a complication of DBS surgery in a patient with Parkinson’s disease
Objective: To describe the unexpected, beneficial effects of cyst formation as a complication of sub-thalamic nucleus (STN) deep brain stimulation (DBS) surgery in a patient…Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study
Objective: To evaluate the long-term safety/tolerability of deutetrabenazine (DTB) in patients with tardive dyskinesia (TD). Week 54 open-label results are reported in this interim analysis.…Motor dysfunctions in rats following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin
Objective: To investigate the targets associated in regulating motor functions following subsequent exposure to stress on the neurotoxicity of lambda-cyhalothrin in rats. Background: Stress that…Hemidystonia Associated with Alexander Disease
Objective: To describe an uncommon movement disorder phenotype of Alexander disease (AD). Background: AD is a rare autosomal dominant disorder that causes progressive leukodystrophy, especially…Whole Exome Sequencing (WES) identifies a TUBB4A Mutation in two Saudi siblings with hypomyelinating leukodystrophy associated with atrophy of basal ganglia and cerebellum.
Objective: To highlight the presentation of TUBB4A mutations. Background: Hypomyelinating leukodystrophy, identified in 2002 by magnetic resonance imaging is a rare heterogeneous group of diseases…Behavioral Changes on the UCSD Huntington’s Disease Behavioral Questionnaire (HD-BQ) Distinguish Patients Transitioning to Manifest Huntington’s disease (HD)
Objective: To utilize the UCSD Huntington's Disease Behavioral Questionnaire (HD-BQ) to assess behavioral changes that distinguish HD gene carriers transitioning to manifest HD. Background: Behavioral…A Descriptive Analysis of a Real-World Population With Huntington Disease-Associated Chorea (HDAC) Treated With Tetrabenazine: Findings From an Electronic Medical Records (EMR) Database
Objective: To examine clinical and treatment information about HDAC in patients (pts) prescribed tetrabenazine (TBZ). Background: Huntington disease is a hereditary movement disorder, with chorea…Parkinson ‘ s disease and Peripheral Nervous System : Wax and Waning Non-motor offs and Levodopa-use Topics
Objective: To relate the non-motor offs theory , sensory signs and levodopa use with neurophysiiology terms in PD Background: Peripheral Nervous System disease concept in…
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 155
- Next Page »